Jason E. Comer, PhD

Dr. Comer is interested in the development of infectious disease models that can be used to evaluate the vaccine and therapeutics under the standards set by the United States Food and Drug Administration (FDA). Dr. Comer plans and oversees preclinical studies to ensure they meet the FDA regulations. Dr. Comer has extensive experience designing and directing Good Laboratory Practice (GLP; 21 CFR Part 58)-compliant studies to test the efficacy of medical countermeasures to a variety of select agents. His end goal is to facilitate the FDA licensure of new vaccines and therapeutics to bio-threat agents and newly emerging diseases.

Search PubMed for Dr. Comer's publications.

SIVS 150x100 logo